Envestnet Asset Management
PJP icon

Envestnet Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Envestnet Asset Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.37M Buy
36,897
+9,741
+36% +$1.05M ﹤0.01% 2558
2026
Q1 		$2.82M Buy
27,156
+8,700
+47% +$919K ﹤0.01% 2754
2025
Q4 		$1.93M Buy
18,456
+168
+0.9% +$16.9K ﹤0.01% 2855
2025
Q3 		$1.69M Sell
18,288
-1,259
-6% -$110K ﹤0.01% 2993
2025
Q2 		$1.56M Buy
19,547
+1,040
+6% +$83K ﹤0.01% 2993
2025
Q1 		$1.6M Sell
18,507
-214
-1% -$18.2K ﹤0.01% 2874
2024
Q4 		$1.55M Sell
18,721
-2,332
-11% -$201K ﹤0.01% 2857
2024
Q3 		$1.83M Sell
21,053
-2,825
-12% -$242K ﹤0.01% 2717
2024
Q2 		$1.96M Buy
23,878
+11,156
+88% +$886K ﹤0.01% 2611
2024
Q1 		$1.02M Buy
12,722
+9,853
+343% +$763K ﹤0.01% 3017
2023
Q4 		$218K Sell
2,869
-95
-3% -$6.79K ﹤0.01% 3788
2023
Q3 		$215K Buy
2,964
+3
+0.1% +$230 ﹤0.01% 3716
2023
Q2 		$224K Sell
2,961
-600
-17% -$45.8K ﹤0.01% 3649
2023
Q1 		$271K Sell
3,561
-988
-22% -$76.2K ﹤0.01% 3492
2022
Q4 		$358K Buy
4,549
+957
+27% +$73.6K ﹤0.01% 3311
2022
Q3 		$256K Buy
3,592
+1
+0% +$75 ﹤0.01% 3453
2022
Q2 		$269K Sell
3,591
-170
-5% -$12.9K ﹤0.01% 3423
2022
Q1 		$299K Buy
3,761
+151
+4% +$11.7K ﹤0.01% 3453
2021
Q4 		$293K Buy
3,610
+234
+7% +$18.5K ﹤0.01% 3430
2021
Q3 		$261K Buy
3,376
+263
+8% +$21.2K ﹤0.01% 3367
2021
Q2 		$250K Sell
3,113
-618
-17% -$49.1K ﹤0.01% 3393
2021
Q1 		$294K Sell
3,731
-37,747
-91% -$2.94M ﹤0.01% 3142
2020
Q4 		$2.96M Sell
41,478
-646
-2% -$43.2K ﹤0.01% 1527
2020
Q3 		$2.69M Sell
42,124
-94,757
-69% -$6.19M ﹤0.01% 1459
2020
Q2 		$8.86M Sell
136,881
-32,811
-19% -$2.04M 0.01% 830
2020
Q1 		$9.34M Sell
169,692
-5,682
-3% -$346K 0.01% 709
2019
Q4 		$11.3M Sell
175,374
-12,690
-7% -$772K 0.01% 746
2019
Q3 		$10.7M Buy
188,064
+1,357
+0.7% +$78.1K 0.01% 724
2019
Q2 		$11.2M Buy
186,707
+170,928
+1,083% +$10.5M 0.01% 680
2019
Q1 		$1.03M Sell
15,779
-27,132
-63% -$1.78M ﹤0.01% 1894
2018
Q4 		$2.68M Buy
42,911
+8,786
+26% +$593K ﹤0.01% 1184
2018
Q3 		$2.51M Buy
34,125
+2,634
+8% +$189K ﹤0.01% 563
2018
Q2 		$2.12M Sell
31,491
-3,187
-9% -$205K ﹤0.01% 791
2018
Q1 		$2.13M Buy
34,678
+2,046
+6% +$135K 0.01% 688
2017
Q4 		$2.09M Buy
32,632
+5,859
+22% +$376K ﹤0.01% 932
2017
Q3 		$1.75M Sell
26,773
-11,471
-30% -$724K ﹤0.01% 966
2017
Q2 		$2.4M Buy
38,244
+6,887
+22% +$413K 0.01% 845
2017
Q1 		$1.84M Buy
31,357
+354
+1% +$20.7K 0.01% 967
2016
Q4 		$1.74M Buy
31,003
+10,002
+48% +$576K 0.01% 985
2016
Q3 		$1.29M Sell
21,001
-15,378
-42% -$1.01M 0.01% 1128
2016
Q2 		$2.31M Buy
36,379
+32
+0.1% +$2.01K 0.01% 955
2016
Q1 		$2.18M Buy
36,347
+11,478
+46% +$702K 0.01% 938
2015
Q4 		$1.74M Sell
24,869
-2,070
-8% -$147K 0.01% 1024
2015
Q3 		$1.79M Sell
26,939
-253,149
-90% -$19.7M 0.01% 1007
2015
Q2 		$21.9M Buy
280,088
+73,453
+36% +$5.72M 0.1% 189
2015
Q1 		$15.8M Buy
206,635
+59,220
+40% +$4.35M 0.08% 243
2014
Q4 		$9.81M Buy
147,415
+19,894
+16% +$1.32M 0.1% 146
2014
Q3 		$8.12M Buy
127,521
+59,357
+87% +$3.67M 0.08% 173
2014
Q2 		$4.16M Buy
68,164
+43,630
+178% +$2.53M 0.04% 255
2014
Q1 		$1.39M Buy
24,534
+12,193
+99% +$692K 0.02% 375
2013
Q4 		$660K Sell
12,341
-69,731
-85% -$3.49M 0.01% 558
2013
Q3 		$3.78M Buy
82,072
+3,020
+4% +$138K 0.05% 216
2013
Q2 		$3.34M Buy
+79,052
New +$3.29M 0.04% 215

Other funds holding PJP

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
DE
Diversified Enterprises Wilmington, Delaware $2.07B AUM 22.34% 1-Year Est. Return

Envestnet Asset Management's PJP Position: Q2 2026 in Review

Envestnet Asset Management increased its Invesco Pharmaceuticals ETF (PJP) stake by 36% in Q2 2026, buying an estimated $1.05M and bringing the position to 36,897 shares worth $4.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

Envestnet Asset Management first reported a position in PJP in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.9M in Q2 2015. 50 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Envestnet Asset Management held 36,897 shares of Invesco Pharmaceuticals ETF worth $4.37M as of Q2 2026.
  • Envestnet Asset Management bought 9,741 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $1.05M.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2558 holding.
  • Envestnet Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 53 quarters since.
  • Envestnet Asset Management's Invesco Pharmaceuticals ETF position peaked at $21.9M in Q2 2015.
  • 50 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.